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Increasing evidence has accumulated within the last decade that neoplastic cells can
produce tumor-specific antigens within the host in which they have arisen (1, 2) . For
example, the fact that preimmunization ofanimals with irradiated tumor cells results in
either rejection or delay of implanted tumor cell lines in the animals has been docu-
mented in a number of tumor-host systems (2, 3) . Secondly, chemically induced tumors
possess tumor-specific antigens even when the tumors are morphologically identical and
arise in a single animal (4) . Thirdly, specifically sensitized lymphocytes to tumor-specific
antigens are cytotoxic for the target cells (5, 6) . Finally, mixed lymphocyte-tumor
reactions have been used to evaluate host reactivity to tumor cell antigens (7-9) .
While the majority of the reports in experimental tumor-host systems have concen-
trated on the humoral mechanisms involved in tumor rejection or enhancement, rela-
tively little attention has been paid to the sequence of events involved in cellularimmune
recognition during tumor growth . Specifically, does the cellular immune system recog-
nize tumor-specific antigens? Do immune cells release mediators of cellular reactivity?
What are the factors responsible for the loss of cellular recognition in a tumor-host
system?
In previous work, Bloom and associates (10) were able to demonstrate the presence of
migration inhibition factors in the supernates of mixtures of lymphocytes and tumor cells
which would inhibit normal guinea pig macrophages . The cytotoxic effect of immune
lymphocytes for neoplastic target cells, as well as the "enhancing" or blocking factors
which negate this effect has been well described by the Hellstroms (11, 12) . However, both
the nature of the blocking factor, its actual mechanism of action, and the reasons for the
appearance on the one hand of a cytotoxic and on the other hand ofa blocking factor are at
the present time unknown .
In view of the above work, it was decided to re-evaluate the host's cellular immune
response to a chemically induced fibrosarcoma in the mouse . Using both direct migration
inhibition and ["Clthymidine incorporation in DNA synthesis as measures of cellular
reactivity to tumor antigen, a sequential study of the immune response to methylcholan-
threne-induced fibrosarcoma in BALB/c mice was undertaken .
The present report indicates that there is a correlation between the degree of
cellular reactivity and the rate oftumor growth . The cellular immune response
to tumor antigens is present in the early stage of the tumor development but
after tumor growth becomes obvious, there is a progressive loss of cellular
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reactivity . Similar results were obtained in migration inhibition and blast
transformation experiments in these mice. The observed loss of cellular reactiv-
ity to tumor cells appearsto correlate with the appearance of blocking factors in
the intraperitoneal fluid of tumor-bearing mice.
Materials and Methods
Mouse Strains .
￿
Female BALBIc mice (Jackson Laboratories, Bar Harbor, Maine) with methyt-
cholanthrene-induced fibrosarcoma were obtained from Dr- Oettgen of the Sloan-Kettering Insti-
tute, New York, and both the methods of inducing the tumor, intraperitoneal passage of tumor
cells, and rate o£ growth of this tumor have been well delineated (l3). This tumor has been
maintained by regular passages (625th) of 2 .5 x 10E tumor cells on the 7th day of tumor growth to
the peritoneal cavity of a new group of female BALBIc mice. Both the number of cells injected
intraperitoneally and the day of passage of the tumor has been kept constant. In most BALBic
mice, tumor growth can he recognized grossly by the 5th day and by the 7th day the abdomen is
fully distended with tumor. The animals die of this tumor within 11-15 days.
Tissue Culture Medium .
￿
RPMI 1640 (Associated Biomedic Systems, Inc-, Buffalo, N. Y.) with
added penicillin (100 Ulml) and streptomycin (50 tcglml) wasused exclusively for all experiments.
At the time of use, 50 UlmI of mycostatin (E. R. Squibb andSons, New York), andan additional 100
gglml ofampicillin (Wyeth Laboratories, Philadelphia, Pa.) and 10%fetal calfserum (FCS)' {;Flow
Laboratories. Inc. Rockville, Md.) were added to the basic medium. The FCS was inactivated by
heating at 56'C for 'r'z h before use.
Tumor (.e11 Lines-
￿
(a) Tumor cells may be obtained directly from the peritoneal cavity of
tumor-bearingmice on the 7th dayafter injection offresh tumor cells into the abdominal cavity of
uninoculated mice. The cells were centrifuged at 1,000 rpm for 10 min; the supernate was
discarded and the cell suspension washed several times in RPMI medium (Associated Biomedic,
Systems, Inc.) .
(h) In vitro cell lines were established as follows: 0.5 x 10E cells obtained from tumor-bearing
mice were inoculated into 250 MI flasks (Falcon Plastics, Div- of Biofiuest, Oxnard, Calif.)
containing 75 ml of the medium described above. The medium was changed twice weekly. When
the tumorcell line reached confluency fin approximately 2 wk), a ne A, flask wasStarted with 0.5 x
l0' cells from the established culture line. These cells grow as a monolayer (often in clones) in the
culture flask and adhere to the bottom of the flask- The phenomenon of contact inhibition (14) is
not seen during the growth ofthese tumor cells. The in vitro tumorcell line hasa doubling time of
8 h.
Antigen Preparation . (al Tumor cells obtained directly from the intraperitoneal cavity of
BALB.ic mice as well as from tissue culture lines were disrupted by sonication at 40 W for 3 min at
4°C with a microtip (Sonifier-cell disrupter model W185; Heat Systems-Ultrasonics, Inc., Plain-
view, N. Y.1. After centrifugation at 10,000 rpm for 30 min, the suspension of sonicated cells was
adjusted to a concentration of I mg/ml (dry weight of whole membranes) and 1-ml aliquots of
disrupted tumor cells were stored at - 70°C until use.
(b) 4-5 million whole tumor cells were treated with 100 tcglml of mitomycin C (Becton-
Dickinson & Cc_ Orangeburg, N. Y.) at 37°C for 'ia h in 1 ml of complete RPMI medium . The
try-pan blue exclusion test (15) revealed that more than 90°Ir of the cells were still viable after
mitomycin treatment but 1 "Clthymidine incorporation studies of the mitomycin-treated cells
indicated that these cells were unable to multiply.
Mouse Immunizations.
￿
(a) Cellular sensitization experiments. As described in the section on
mouse strains, tumor cells were obtained from the peritoneal cavity of tumor-bearing mice . These
cells were washed once andsuspended in normal saline . After counting and checking the viabiIity
by the trypan blue method, a group of mice were injected with 2-5 x 10" tumor cells intraperito-
neally- At appropriate intervals after tumor injection, these mice were used for the migration
inhibition and blast transformation experiments.
(b) Cellular cytotoxicity experiments . For these studies, mice were immunized intraperito-
ncally" with two doses of 4 x 106 mitomycin-treated tumor cells administered 9 days apart. Spleen
cells from these mice were obtained as described below . In order to obtain the peritoneal cells for
Abhreuiatit)ns used in this paper: FCS. fetal calf serum; PIIA. phytohemagglutinin .R. M. BHATNAGAR, J . B . ZABRISKIE, AND A . R. RAUSEN
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cytotoxicity studies (16) both normal mice and mice immunized with mitomycin-treated tumor
cells were injected intraperitoneally with 0.5 ml of thioglycollate (16) . Unimmunized mice were
sacrificed 6 days after the injection of thioglycollate . Immunized mice were injected with thiogly-
collate on the 3rd day afterthe second injection ofmitomycin-treated tumor cells and sacrificed 6
days later . Spleen cells andperitoneal exudate cells were harvested from both groups of mice .
Capillary Migration Inhibition Techniques .
￿
The lymphocyte migration inhibition technique
currently in use is described as follows: BALB/c mice are sacrificed by cervical dislocation at
varying intervals of the time after the initiation of intraperitonealtumor. The spleen is removed
and placed in RPMI 1640 medium . Splenic lymphocytes are dissociated by gently pressing the
spleen through the steel gauze nets (80 nets per square inch) with RPMI 1640 medium (no FCS) .
The splenic cells are centrifuged at 1,000rpmfor 10 min. Contaminating red blood cells are lysed
by theaddition of 5 ml of 0.83% ammonium chloride (17) . Thespleen cellsarethen washed twice in
5ml ofRPMI 1640 medium andcentrifuged at 1,000rpmfor 10 min. The cells areresuspended in 10
ml of complete RPMI 1640 (10% FCS) . Trypan blue exclusion tests indicate that more than 95% of
the cells are viable and thesuspension is adjusted to a final concentration of 4 x 10' cells/ml . The
capillaries are then loaded with this cell suspension, sealed at one end with Seal Ease (Clay-
Adams, Inc., Parsippany,N. J.), spun at 900rpmfor 10 min, and cut at the cell-fluid interface . The
cut capillaries are placed in small planchettes and filled with tissue culture medium containing
various concentrations of the antigen to be tested . The planchettes are sealed with cover slips and
allowed to incubate for 12-18 h in a 5% C02-air gasphaseincubator at 37°C . The fans of migrating
leukocytes are then projected on tracing paper and the outlines of the fans drawn on the paper .
These drawings are cut out and weighed. The degree of sensitivity of the leukocytes to their
specific sensitizing antigen is expressed as the percentage of inhibition . This is calculated as
follows :
average migration of cells with antigen
￿
x 100 = % migration index,
average migration of cells without antigen
where% migration index - 100 = % inhibition .
['"C]Thymidine Incorporation Studies .
￿
(a) Spleen cells . Measurement of the incorporation of
['"C]thymidine (New England Nuclear, Boston, Mass .) by sensitized splenic lymphocytes in the
presence of tumor antigens was carried out using a micro method modification of the standard
procedure (18) . BALB/c mice were sacrificed at varying intervals of time afterthe initiation ofthe
intraperitoneal tumor and 2 x 10' ml splenic lymphocytes were suspended in RPMI 1640 with
added 10% inactivated FCS. Since different lots ofFCS varied considerably with respect to their
ability to stimulate unsensitized spleen cells to transform, only those lots of FCS which gave
minimal transformation of normal lymphocytes were used in the medium . The spleen cells were
distributed at a concentration of 2 x 10 5 cells/0.1 ml in the microplate (Microtest II tissue culture
plate, Falcon Plastics, Div. of BioQuest). 1 x 10 3 mitomycin-treated tumor cells in 0.1-ml vol were
added to the spleen cells . Control plates of spleen cells without tumor cells were brought to the
same vol of 0.2 ml with RPMI 1640 medium . Phytohemagglutinin (PHA) at a concentration of 50
wg/0 .1 ml was used as a control . Mitomycin-treatedtumor cells were also incubatedalone in 0.2-ml
vol. After48hof incubation at 37°C in CO 2-air gas phase incubator, 0.01 WCi of ['"C]thymidine was
added to each well . After 24 h of incubation, the cells were collected on a multiple automated
sample harvester [Hartzman et al . (19)], dissolved in Aquasol (New England Nuclear) and
counted for5min on ascintillation counter (Liquid Scintillation Spectrometer, Packard model no .
3330 ; Packard Instrument Co ., Inc., Downers Grove, Ill.) .
(b) Whole blood method . Since measurement of ['"C]thymidine incorporation by sensitized
lymphocytes in spleen cell suspensions necessitates sacrificing the animal, other methods were
devised to measure the degree of blast transformation repetitively in a single animal . At different
days after the induction of tumor, mice were bled from the left orbitalsinus with heparinizedsmall
glass pipettes . 0.5 ml o_ bloodwas obtained without sacrificingthe mouse and dilutedwith 2.5 ml
ofRPMI 1640 without 10% FCS and5 x 10 -5M 2-mercaptoethanol . From this dilution, 0.1 ml was
distributed in each well . Addition of tumor cells and the rest of the procedure was followed as
described above for the spleen cells . Often, the same mice were bled twice at an interval of 4-6
days .
The blastogenic index for both methods was calculated from the ['"C]thymidine incorporation
(in counts per minute) as follows :842
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(peripheral blood or spleen cells + tumor cells) - (tumor cells)
(peripheral blood or spleen cells) .
Cellular Cytotoxicity Studies.
￿
Tumor cells were labeled with "Cr according to the methods of
Brunner et al. (20, 21) in which "Cr in the form of sodium chromate (Amersham/Searle Corp.,
Chicago, Ill.) was added at a concentration of 100 /Ci/4-5 million target cells. The cells were then
incubated with the label for 30 min at 37°C and then washed with Eagle's balanced salt solution to
remove excess '"Cr. For the cytotoxicity experiments, spleen cells obtained from mice immunized
with mitomycin-treated tumor cells (see MouseImmunization section) and tumor target cells were
mixed in a ratio of 100:1 spleen/target cells and placed in 1 ml of complete RPMI 1640 medium.
Because of the possibility that immune macrophages were needed in cytotoxicity experiments (18),
other experiments were carried out in which equal numbers of spleen cells and peritoneal cells
from both immunized and normal mice were added to tumor target cells at a ratio of 100
spleen/peritoneal cells to one target cell . These suspensions were also made up in 1 ml of complete
RPMI 1640 medium. All suspensions were then placed in a5% CO2-air gasphase incubator at 37°C
for 8 h on a continuous rotator (8 rpm). Total release of the labeled ''Cr on the target cells was
determined by freeze-thaw lysis of a comparable number of target cells. Spontaneous release of
"Cr in the presence of lymphocytes obtained from nontumor-bearing BALB/c mice served as a
control . After incubation, each mixture of cells was centrifuged at 800 rpm for 5 min and 0.5 ml of
supernate was carefully removed and sampledfor "Cr release. The radioactivity of these samples
was measured in a well-type gamma counter, Packard model no. 3002 (Packard Instrument Co.,
Inc.). The results were then expressed as the amount of radioactivity released from target cells in
the presence of tumor immune cells as compared to the radioactivity released from target cells in
nontumor immune cells. The percent of lysis was calculated as follows:
("Cr release in the presence of _ (''Cr release in the presence of
immune cells)
￿
nonimmune cells)
￿
x 100.
(maximum "Cr release from
￿
("Cr release in the presence of
target cells)
￿
nonimmune cells)
Blocking Experiments. Intraperitoneal fluid was collected from tumor-bearing mice on the 7th
day after induction of tumor. Tumorcells were separated by centrifugation at 1,000 rpmfor 10 min
and the supernatant fluid was collected. For each experiment, fresh fluid was obtained. Tumor-
bearing mice were also bled from theorbital sinuses. The sera obtained from anumber ofthemice
were pooled and were also used for blocking experiments.
To study the protective effect of this fluid on tumor cells in the cytotoxic experiments described
above, 0.2 ml of intraperitoneal fluid or immune serum was added to the incubated mixture of
immune cells and tumor cells. Forcontrol studies, normal pooled mouseserumor FCSwas used.
Serological Studies.
￿
Goat antisera raised against mouse IgG, IgM, and IgA were obtained
from Meloy Laboratories, Inc., Springfield, Va. Intraperitoneal fluid from mice inoculated with
tumor wascollected, and this fluid was studied for thepresence of different classes ofimmunoglob-
ulins by immunodiffusion in 1% noble agar. The antisera were lyophilized and mixed with 1 ml of
intraperitoneal fluid. These mixtures were incubated for 2 h at 37°C and then overnight at 4°C.
The resulting precipitate was centrifuged, andthe supernate wastested for (a) residual immuno-
globulin with double-diffusion studies; and (b) residual-blocking effect in the cytotoxic experi-
ments .
Results
Migration Inhibition Experiments .
￿
A total of 77 mice were injected with 2.5
x 106 tumor cells intraperitoneally and divided into groups of 7 mice per group.
Eight mice served as 0-day controls. Each group of mice was sacrificed on
successive days up to the 11th day. The last group of mice was sacrificed on the
13th day after injection. Fig. 1 is a photograph of the capillary migration
patterns of spleen cells obtained from tumor-bearing mice in the presence or
absence of tumor antigen. As can be seen, the migration patterns of the fansR. M. BHATNAGAR, J. B . ZABRISKIE, AND A. R. RAUSEN
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FIG . 1 A photomicrograph of the capillary migration patterns of spleen cells in the
presence or absence of tumor antigens. Note the smaller fans on the right side of the
photograph indicating specific inhibition of spleen cells by tumor cell antigens . x 20 .
with added antigen (right side of photograph) are considerably smaller than the
fan patterns in medium without antigen (left side of photograph) . The experi-
mentswere always run in triplicate and only those experiments in which the fan
size of a given well was similar in size to the other wells were considered valid .
The results of a number of migration inhibition studies are summarized in
Fig . 2 . Several observations are worthy of comment . There is a significant
cellular response present on the 1st day after injection of tumor cells which
reaches a peak on the 2nd day . After this time, there is a gradual loss of cellular
reactivity to the tumor cells . The progressive loss of cellular recognition for
tumor cells correlates with the rapid accumulation of ascites fluid and cells in
the peritoneum of the mouse on the 6th or 7th day after tumor injection . After
the 10th day following tumor injection, only stimulation values (migration
beyond control) were seen in all mice .
Stimulation ofDNA Synthesis .
￿
32 mice were used for the [' 4C]thymidine
incorporation studies of spleen cells . On successive days after the injection of844
￿
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FIG. 2 .
￿
The average migration inhibition values of groups of mice sacrificed on successive
days aftertumorinduction . Peak cellular reactivity to tumorantigens is seen on the 3rdday
after tumorinduction and slowly declines with progressive tumor growth .
tumor cells 4 mice were sacrificed each day up to the 7th day and the spleen cells
were obtained for DNA synthesis experiments. The last group of mice was
sacrificed on the 12th day after tumor injection . Five unimmunized mice served
as controls . For the whole blood studies 20 mice were injected with tumor cells .
The protocol for these studies is as follows : four mice were sacrificed 24 h after
tumor inoculation and successive groups ofmice were sacrificed on the 3rd, 5th,
and 7th day after tumor injection . The last group ofmice was sacrificed on the
12th day.
The results of spleen cells blastogenesis to mitomycin-treated tumor cells are
summarized in Fig . 3. As can be seen, there is a significant immune response
within 24 h after the injection oftumor cells. This cellular response disappears
rapidly on the 2nd day and remains so up to the time mice die of this tumor. Of
interest was the fact that there is an increase in the background count of the
spleen cells as the tumor progresses . The PHA response of spleen cells persists
until the terminal stage oftumor growth .
The results of whole blood blastogenesis are summarized in Fig . 4. There isR. M. BHATNAGAR, J. B. ZABRISKIE, AND A. R . RAUSEN
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FIG . 3 .
￿
The average stimulation index values ofBALB/c spleen cells to mitomycin-treated
tumor cells . Note the single peak value 24 h after live tumor cell inoculation .
FIG . 4 .
￿
The average stimulation index values of BALB/c peripheral blood lymphocytes to
mitomycin-treated tumor cells . Peak values are again noted 24 h after live tumor cell
inoculation with a more gradual decline in cell reactivity .
rapidDNA synthesis within 24 h after induction oftumor. However, in contrast
to the rapid disappearance of cellular stimulation seen in the spleen cells, the
loss of cellular response to tumor antigens in whole blood is more gradual . It is
not until the 7th day that there is a disappearance of the cellular response to
tumor antigens and this lack of cellular reactivity remains constant until the
death of the animal .
Cellular Immune Responses to the Lower Dose of Tumor Cell Inocula-
tion .
￿
The rapidity with which cellular reactivity to tumor antigens was lost in846
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The average migration inhibition values of groups of mice sacrificed on successive
days after lower dose of tumor cells inoculation . Note peak cellular reactivity to tumor
antigens on 14th day after tumor inoculation and gradual decline with progressive tumor
growth .
the experiments described in Fig . 2 suggested that the host's immune system
was overwhelmed by the initial tumor cell inoculation . In order to test this
hypothesis, the experiments described in Fig . 2 were repeated with a lower
inoculating dose oftumor cells .A total of 45 mice were injected intraperitoneally
with 4 x 104 number oftumor cells . Using this dose, more than 97% ofBALB/c
female mice developed the tumor around the 3rd wk after inoculation . These
animals died of the tumor within 4-5 wk . The total number of injected mice
were divided into groups of four animals . Four other normal mice served as 0-
day controls . Each group of injected mice were sacrificed at differentintervals as
shown in Fig . 5 . As noted, there is significant cellular response present on the
7th day after inoculation of tumor cells . The peak response is reached by the
14th day . After this period of time, there is agradual loss of cellular reactivity to
the tumor cells . From the 29th day onwards, these mice do not show any
significant cellular response . This gradual loss of cellular reactivity corresponds
to the grossly accumulating intraperitoneal tumor in these animals .
36 mice were studied for [14C]thymidine incorporation with spleen cells and
the whole blood . Four mice served as 0-day control . Each group offour mice were
sacrificed at differentintervals as shown in Fig . 6. As canbe seen (straight line),
there is a significant cellular response by the 11th day after tumor inoculation .
This response gradually disappears by the 19th day and remains negative up to
the time mice die ofthis tumor . The dotted lines in Fig . 6 summarize the results
of whole blood blastogenesis in the same animals . In general, the cellular
response of the whole blood method to tumor antigens correlates well with the
spleen cells response . The peak ofDNA synthesis comes on the 14th day, and
then there is gradual loss of reactivity up to the 19th day. After this period, the
cellular response to the tumor antigen in these animals is essentially negligible
up to the time ofthe death of the animals .
In an effort to determine the cytotoxicity effects of sensitized spleen cells with
and without the addition of peritoneal cells, the following cytotoxicity experi-
ments were performed: Spleen cells obtained from tumor immunized mice were
incubated with "Cr-labeled tumor cells . Similar experiments were carried outx (1)
c
c 0
0
E
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FIG . 6 .
￿
The average stimulation index values of spleen cells ("-") and peripheral whole
blood (O---O) to mitomycin-treated tumor cells after lower dose inoculation of tumor cells in
BALBIc mice . Peak values are noted on the 11th dayand 14th day for spleen cells andwhole
blood cells, respectively . Values return to normal by the 19th day .
TABLE I
Spleen Cell-Mediated Cytotoxicity
Abbreviations : 1, immune ; N, normal ; R, release; SC, spleen cells ; SP, spontaneous ; T, total .
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with peritoneal cells alone and peritoneal cells mixed with sensitized spleen
cells . The results are summarized in Tables I and II .
Cellular Cytotoxicity Studies .
￿
TableI summarizes the results of the cytotox-
icity experiments using 5 different mice . A perusal of columns two through four
demonstrates that there is no significant difference in the release of "Cr from
target cells when incubated with either normal spleen cells or immune spleen
cells . In addition, the spontaneous release of"Cr from the tumor cells correlates
quite well with the release of -"Cr from the normal spleen cells.
In contrast, Table II shows the results of a study of 4 mice in which the
immune spleen cells were mixed with immune peritoneal cells . As can be seen,
there is a significant release of"Cr from the target cells . The percent cytotoxic-
ity shown in the fifth column of this table clearly indicates that there is a
significant cytotoxic effect of immune spleen cells for target cells when mixed
with peritoneal cells .
No .
Average
TR
"Cr released
SP R
from each set
N SC R
of exp .
I SC R
Cytotoxic "Cr
released by
ISC
1 825.2 270 .1 272.2 297 .0 4 .8
2 615.5 136 .0 135.6 153 .4 3 .6
3 709.0 203.0 205.2 226 .1 4.5
4 506.2 208 .0 210.0 202 .1 0
5 752.0 138.9 142.8 165.5 4.3848
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TABLE II
Mixed Spleen Cell andPeritoneal Cell Cytotoxicity
Abbreviations: IPC, immune peritoneal cells; ISC, immune spleen cells; NPC, normal peritoneal
cells; NSC, normal spleen cells; R, release ; SP, spontaneous; T, total.
When immune peritoneal cells alone are incubated with the "Cr-tagged
tumor cells, there is also a marked cytotoxic effect. As seen in Table III,
cytotoxicity up to 88% was achieved with immune peritoneal cells. If one
compares these results with the cytotoxicity values achieved with immune
spleen cells and immune peritoneal cells (Table II), it is apparent that immune
peritoneal cells play the major role in the cytotoxic effect on tumor cells. While
not shown, spleen cells obtained from mice inoculated either intraperitoneally
or subcutaneously with live tumor cells also failed to show any cytotoxic effects.
Blocking Experiments. The results of the blocking effect of the cell-free
intraperitoneal fluid are shown in the extreme right-hand column of Table III.
In the presence of the cell-free peritoneal fluid, an average of only 20.5%
cytotoxicity values was obtained in the presence of the peritoneal fluid as
compared to approximately 70% cytotoxic values in the absence of the fluid.
Essentially identical results were obtained when pooled immune sera were used
in place of the intraperitoneal fluid.
Fig. 7 shows the effect of immune cells on tumor cells when they are incubated
together for 6-8 h at 37°C and were tested with trypan blue for viability. In this
photograph, tumor cells are surrounded by numerous immune peritoneal cells.
Trypan blue has been excluded by the immune cells and has been taken up by
the tumor cells demonstrating the killing effect of the immune peritoneal cells .
Immunoglobulin Absorption Studies. In an effort to determine whether
mouse immunoglobulins were responsible for the blocking effect on cytotoxicity
experiments, absorption studies with goat antimouse immunoglobulins were
carried out as described in the Materials and Methods . The results of these
experiments are depicted in Fig. 8. As can be seen, all three major classes of
immunoglobulins (IgG, IgM, and IgA) are present in the intraperitoneal fluid
(Fig. 8 a). After absorption with specific antisera, lines of identity to the
specifically absorbed class of immunoglobulins were no longer detected. These
studies demonstrate that IgG, IgM, and IgA have been absorbed from the
intraperitoneal fluid (Figs. 8 b, c, and d).
The results of absorbed intraperitoneal fluid studies are shown in Table IV.
As can be seen, there is good cytotoxic effect of the immune peritoneal cells
(91%) and intraperitoneal fluid effectively blocked the cytotoxicity (11.5%) .
Experiment numbers 6-8 reveal that prior absorption with specific antisera
No.
TR
Average "Cr released
SP R
from each set of
NSC + NPC R
exp.
ISC + IPC R
Cytotoxic
"Cr release
1 798 229 230.9 438.2 36 .7
2 798 229 230.9 359.0 22 .8
3 1,102.1 271 .2 269.8 429.2 19.0
4 1,102.1 271 .2 269.8 451.4 21 .6R . M . BHATNAGAR, J . B . ZABRISKIE, AND A . R . RAUSEN
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aFIG. 7 .
￿
Trypan blue exclusion photomicrograph of tumor cells with immune peritoneal
cells incubated for3h at 37°C in 5% C02-airgasphase . Note : Killed tumor cells with trypan
blue uptake is surrounded by alive immune peritoneal cells . x 120 .
FIG. 8 .
￿
(a) Double diffusion studies carried outwith intraperitoneal fluid andantimouse
immunoglobuhns . Center well contains intraperitoneal fluid . Top well contains antiserum
directed against mouse IgG . Antisera to mouse IgM and IgA are placed in left and bottom
wells respectively . (b, c, and d) Show loss of specific precipitation lines after absorption
against specific immunoglobulin antiserum .
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TABLE IV
The Effect ofImmunoglogublin Absorption on Blocking ofCytotoxicity
TABLE V
Cytotoxicity ofImmune Peritoneal Cells Obtained from Mice Immunized with SV40-
Transformed Fibroblasts and Methylcholanthrene-Induced Fibrosarcoma
* Cells from mice immunized with SV40-transformed fibroblasts .
$ Cells from mice immunized with methylcholanthrene-induced fibrosarcoma .
Average 5'Cr
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directed against the major mouse immunoglobulin classes had no effect on the
blocking activity of the intraperitoneal fluid .
Immune Response Specificity . In an effort to determine whether the im-
mune response of the peritoneal cells was specific for only BALB/c methylcholan-
threne-induced fibrosarcoma tumor cells, the following experiments were car-
ried out . BALB/c mice were immunized with 3 injections of mitomycin-treated
SV40-transformed fibroblasts . The results of these immune peritoneal cells on
methylcholanthrene-induced fibrosarcoma cells are seen in Table V . As can be
seen, there is no significant release of "Cr using SV40-immunized peritoneal
cells (only 10%), as compared to the specifically immunized peritoneal cells
(chromium release, 90.9%) . These results strongly indicate that the cytotoxic
effect of the peritoneal cells obtained from the injection of methylcholanthrene-
induced tumor cells is specific for those tumor cells alone .
The question whether or not the blocking effect of the intraperitoneal fluid
obtained from methylcholanthrene-induced tumor mice was specific for those
released
from each
set of exp .
Cytotoxic
"Cr release
%
1 Total release 667
2 Spontaneous release 155
3 Normal peritoneal cells 161 1.1
4 Immune peritoneal cells 620 90.8
5 Immune peritoneal cells with intraperitoneal fluid 214 11.5
6 Immune peritoneal cells with IgG absorbed intraperitoneal fluid 234 15.4
7 Immune peritoneal cells with IgM absorbed intraperitoneal fluid 278 24 .0
8 Immune peritoneal cells with IgA absorbed intraperitoneal fluid 269 22.2
Methylcholanthrene-induced fibrosar-
coma cells tagged with "Cr
Average "Cr re-
leased from each
set of exp .
Cytotoxic "Cr re-
lease
1 Total release 667
2 Spontaneous release 155
3 Normal peritoneal cells 161 1 .1
4 Immune peritoneal cells* 210 10
5 Immune peritoneal cells$ 620 90 .8852 CELLULAR IMMUNE RESPONSES TO FIBROSARCOMA
TABLE VI
Blocking Specificity ofCell-Free Intraperitoneal Fluid on Cytotoxicity
diation-induced BALB/c leukemia
tumor cells alone was investigated next . Table VI indicates that intraperitoneal
fluid from methylcholanthrene-induced tumor mice (experiment 5) completely
blocked the cytotoxicity effect of the peritoneal cells (11 vs . 90 .8%) . In contrast,
intraperitoneal fluid obtained from animals inoculated with different tumor
cells did block the cytotoxicity effect of specific tumor-peritoneal cell interactions
(53%), but it was not nearly as effective as specific intraperitoneal fluid obtained
from methylcholanthrene-induced tumor mice . These results suggest that there
may be common antigens shared by these two different tumor cells since they
were produced in the same strain of mice . However, the blocking effect is far
more pronounced when intraperitoneal fluid specific for the tumor cell line is
used.
Discussion
The examination of the cellular immune response to tumor antigens in an
experimentally induced fibrosarcoma in BALB/c mice has resulted in a number
of observations which are worthy ofcomment . First, it is clear that the use of the
in vitro technique of capillary migration of mouse spleen cells is an accurate
reflection of the state of cellular reactivity to tumor antigens . As noted in our
studies, there was definite recognition of the tumor antigens in the first 2 days
after tumor induction which rapidly disappeared culminating in stimulation
values . While stimulation values were consistently seen in these mice towards
the time of their death from tumor, the reasons for these values are poorly
understood . The presence of a chemotactic factor associated with tumor cell
antigen has not been excluded . Nor has the possibility been ruled out that the
antigen-antibody complexes involving tumor antigen may be involved in this
reaction .
The blastogenic studies strongly support the findings observed with the
migration inhibition technique . Cellular recognition oftumor antigen was again
noted early in the course of the tumor growth . The early appearance of
['4Clthymidine incorporation in mouse spleen cells (24 h) is surprising and
Methylcholanthrene-induced fibrosar-
coma cells tagged with "Cr
Average ''Cr re-
lease from each set
of exp.
Cytotoxic "Cr re-
lease
1 Total release 667
2 Spontaneous release 155
3 Normal peritoneal cells 161 1.1
4 Immune peritoneal cells 620 90 .5
5 Immune peritoneal cells with specific 214 11.5
intraperitoneal fluid
6 Immune peritoneal cells with nonspe- 427 53.0
cific intraperitoneal fluid from ra-R . M . BHATNAGAR, J . B . ZABRISKIE, AND A . R . RAUSEN
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suggests that ['4Clthymidine incorporation is a more sensitive indicator of
tumor antigen recognition. However, when the lower dose of tumor cells was
inoculated, there was early appearance of migration inhibition factor . After the
2nd day following tumor injection no blast transformation was noted in the
mouse spleen cells, yet they were capable of responding to PHAup to the late
stages of tumor growth . In any event, both methods (whole blood, as well as
isolated spleen cells) showed a rapid loss of ability to recognize tumor antigens .
The results obtained with a lower inoculating dose strongly support the concept
that cellular recognition of tumor cells is present during the early stages of
tumor growth . This loss of reactivity correlates well with the gross appearance
of tumor growth .
The results obtained in the cytotoxic experiments are difficult to explain but
do suggest that the specific cell populations may be important in the observed
cytotoxicity for tumor target cells . For example, sensitized spleen cells were not
cytotoxic per se while immune macrophages exhibited marked cytotoxicity for
tumor cells. These results may be open to two interpretations. The fact that
cytotoxicity may be unique for macrophages suggests that the "angry" macro-
phage concept set forth by Macaness (22) is operating in these studies . Once
immunized with tumor cells, the macrophage is the killer cell and not the
lymphocyte . Alternatively, the macrophage is the effector cell in the cytotoxic
experiments and has been "primed" by a sensitized lymphocyte . Experiments in
which supernates from sensitized lymphocytes are mixed with normal macro-
phages should be performed in order to further delineate the respective roles of
lymphocyte and macrophage .
Perhaps the most striking finding was thepresence of "blocking" factorsin the
intraperitoneal fluid during growth of the tumor. This factor appears early
during the course of tumor growth and effectively blocks the cytotoxic effects of
macrophages for tumor target cells . The nature of this blocking factor is, at
present, unknown . Absorption studies with antisera raised against the major
mouse immunoglobulin classesstrongly suggest thatimmunoglobulinspersedo
not play a role in this blocking effect . The same would apply to the possibility
that antigen-antibody complexes are involved in the blocking effect . Theconcept
that excess tumor antigen may be responsible for the blocking effect has not
been ruled out. Preliminary experiments on Sephadex G 100 indicate that the
factor is ofhigh mol wt (>150,000) and is protein in nature (destroyed by trypsin
and pepsin). It is planned to use other molecular sieves to determine the exact
size ofthe molecule responsible for the blocking effect .
The specificity oftheeffector cells was demonstrated bythefact that cytotoxic-
ity occurred only with specific immune cells and no cytotoxicity was observed
with irrelevant immune peritoneal cells. In contrast, intraperitoneal fluid ob-
tained from irrelevant tumor mice did exert a blocking effect on specific target
cells . However, the effect was never as pronounced as the blocking action of
specific intraperitoneal fluid. These results suggest that some of the blocking
effect might be due to antigens common to both tumor cells lines, since both
lines were derived from the same strain of mice .
In conclusion, the experiments described above indicate that it is possible to
sequentially monitor the presence and subsequent loss of cellular reactivity to854
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tumor antigens in an experimentally induced tumor model in mice . Using two
different in vitro parameters of cellular reactivity, it has been shown that this
loss of cellular reactivity to tumor antigen correlates quite well with both the
tumor growth and the appearance of a "blocking factor" in the peritoneal cavity
of these mice . The nature of the blocking factor is now under investigation, but
preliminary investigations suggest that major classes of mouse immunoglobu-
lins per se are not responsible for the blocking of the cytotoxicity experiments .
The reproducibility of the experiments coupled with our ability to further
examine the nature of the blocking factor(s) may have important implications in
our understanding of the mechanisms whereby tumor growth occurs .
Summary
Several in vitro parameters of cellular immunity were examined in BALB/c
mice with an experimentally induced fibrosarcoma tumor . The results of capil-
lary migration of spleen cells in high tumor cell dose inoculated mice show
appearance of cellular immune response in the early stages of the tumor growth .
As the tumor progresses, the cellular response declines and rapidly disappears,
culminating in stimulation values near the time of the death of these mice .
The blastogenic studies also show early cellular recognition oftumor antigen
by mouse spleen cells and whole blood Z24 h) . After the 2nd day followingtumor
injection, no blast transformation is noted . However, the results obtained with a
lower inoculating tumor cell dose demonstrate an initial cellular recognition on
the 7th day . This response gradually disappears by the 19th day and remains
negative up to the time of the death of these mice .
This cellular immunity was confirmed by the cytotoxic experiments showing
that the primary cells responsible for this cellular reactivity were the immune
cells . An interesting finding was the presence of a factor(s) capable of blocking
the cytotoxic effect . The nature and mechanism of this blocking factor(s) is now
under investigation .
Received for publication 24 October 1974 .
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